Cargando…
Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines
BACKGROUND: Anthracycline cardiotoxicity (AC) may manifest years after treatment (long-term cardiotoxicity). There is little data on the incidence and natural history of AC in the current context, with protocols including lower anthracycline doses. The present study prospectively evaluated the incid...
Autores principales: | Caballero, Rebeca Mata, Antolín, José María Serrano, Hernández, Rosa María Jiménez, Calle, Pedro Talavera, Ruigómez, Alejandro Curcio, Arrojo, Silvia del Castillo, Abad, Catherine Graupner, Varela, Carmen Cristóbal, Martín, Joaquín Jesús Alonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007491/ https://www.ncbi.nlm.nih.gov/pubmed/32329038 http://dx.doi.org/10.5603/CJ.a2020.0062 |
Ejemplares similares
-
Anthracycline Cardiotoxicity in a Patient with Diffuse Large B-Cell Lymphoma: A Case Report
por: Teixeira da Silva, Francisco, et al.
Publicado: (2020) -
Delayed Onset Anthracycline-Associated Cardiotoxicity Presenting as Acute Decompensated Heart Failure Seven Years After Chemotherapy Completion
por: Tran, Dan B, et al.
Publicado: (2021) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)